Fig. 5From: Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR dataResults of subgroup analyses. Notes: a Subgroup analysis based on sample source. The tissue subgroup had significant heterogeneity (I2 = 95.8%, p = 0.000). (1: tissue, 0: blood) b Subgroup analysis based on cancer type. The adenocarcinoma and the squamous cell carcinoma both had significant heterogeneity (1: adenocarcinoma, 0: squamous cell carcinoma)Back to article page